NL-OMON26110已完成不适用
ybridos PoC:<br>A double blind, randomized, cross-over placebo controlled pilot study to investigate the subjective and physiological efficacy and safety of Lybridos in healthy female subjects with Female Sexual Dysfunction.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 13
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Thirteen (13) premenopausal and postmenopausal women with Hypoactive Sexual Desire Disorder (HSDD), with or without Female Sexual Arousal Disorder (FSAD).
排除标准
- •Subjects will not be eligible for inclusion if one of the following criteria applies:
- •1. Use of oral contraception containing anti-androgens (Like Diane 35 or Minerva);
研究者
相似试验
进行中（未招募）
不适用
ybridos PoC: A double blind, randomized, cross-over placebo controlled pilot study to investigate the subjective and physiological efficacy and safety of Lybridos in healthy female subjects with Female Sexual Dysfunction - Lybridos PoCFemale Sexual Dysfunction, specifically Hypoactive Sexual Desire Disorder, with or without Female Sexual Arousal Disorder.MedDRA version: 9.1Level: LLTClassification code 10020933Term: Hypoactive sexual desire disorderEUCTR2008-007704-28-NLEmotional Brain13
已完成
不适用
@home: a study to investigate the subjective and physiological efficacy and safety of Lybrido and Lybridos in the domestic setting in healthy female subjects with Female Sexual DysfunctioFemale Sexual Dysfunction (FSD), Hypoactive Sexual Desire Disorder, Female Sexual Arousal Disorder, FSDNL-OMON28613Emotional Brain120
已完成
不适用
A Crossover designed, Placebo Controlled Study to evaluate the effects of supplement REPHYLL on delayed onset muscle soreness (DOMS) in humans.CTRI/2019/05/019366Aurea Biolabs P Ltd20
进行中（未招募）
1 期
A study comparing immediate-release oral Levodopa and L-dopa/carbidopa intestinal gel over cognition and mood in non-demented Parkinson?s disease (PD) patientsParkinson diseaseEUCTR2015-002631-17-ESInstitut de Recerca del Hospital de la Santa Creu i Sant Pau18
进行中（未招募）
不适用
A randomized, double-blind, two way cross-over, proof of concept study to compare the efficacy, safety, pharmacokinetics and pharmacodynamics of two-week oral administration of QAV680 versus placebo, with an extended open-label inhaled corticosteroid period, in steroid-free, mild to moderate persistent asthma patientsEUCTR2008-005168-15-DEovartis Pharma Services AG50